OBB Newsletter

  • Enter your e-mail address below to subscribe to the Orange Book Blog newsletter. If a new post is added during the day, you'll receive it by e-mail the next morning.

Enter your email address:

Delivered by FeedBurner

OBB RSS Feed

  •  

Disclaimer

  • Orange Book Blog is published for informational purposes only; it contains no legal advice whatsoever. Publication of Orange Book Blog does not create an attorney-client relationship. Orange Book Blog is Aaron Barkoff's personal website and it is intended for other attorneys. Orange Book Blog is not edited by McAndrews, Held & Malloy, Ltd. ("MHM") or its clients. No part of Orange Book Blog--whether information, commentary, or other--may be attributed to MHM or its clients. MHM represents many companies in the pharmaceutical and biotechnology industries, and therefore Orange Book Blog may occasionally report on news that relates to MHM clients. Orange Book Blog will always strive to be unbiased. All information on Orange Book Blog should be double-checked for its accuracy and current applicability. -- © Aaron F. Barkoff 2006-2017

« District Court Finds Apotex and Impax Infringe AstraZeneca's Formulation Patents on Prilosec | Main | District Court Invalidates McNeil's Formulation Patent on Pepcid Complete, Relying on KSR v. Teleflex »

June 05, 2007

Comments

Dr. Sreenivasulu N.S, Professor of IPR and Biotechnology

Myself is an Associate Professor of Law with Doctorate on IPR and Biotechnology from India. I have authored a book on Biotechnology and Patent law, currently working on a new book on Biotechnology law. I am very happy to learn about your conference. Thank you very much

The comments to this entry are closed.